EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Associations between gut microbiota characteristics and non‐motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients

Agnieszka Gorecka-Mazur iD, Anna Krygowska-Wajs, Agata Furgala, Jiaqi Li, Benjamin Misselwitz, Wojciech Pietraszko, Borys Kwinta, Bahtiyar Yilmaz iD

Neurogastroenterology & Motility · 2024-08 · 36 (8)

DOI: 10.1111/nmo.14846 ↗

At a glance

Journal article in Neurogastroenterology & Motility, published online on 2024-06-14. Written by Agnieszka Gorecka-Mazur and 7 co-authors. Institution: Department of Pathophysiology, Jagiellonian University, Collegium Medicum, Kraków, Poland. Major MEDLINE topics: Parkinson Disease, Gastrointestinal Microbiome, Deep Brain Stimulation. Cited 14 times so far (Crossref); 95 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Narodowe Centrum Nauki.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The gut microbiota has been implicated in Parkinson's disease (PD), with alterations observed in microbial composition and reduced microbial species richness, which may influence gastrointestinal symptoms in PD patients. It remains to be determined whether the severity of gastrointestinal symptoms correlates with microbiota variations in PD patients treated pharmacologically or with subthalamic nucleus deep brain stimulation (STN‐DBS) therapy. This study aims to explore how these treatments affect gut microbiota and gastrointestinal symptoms in PD, identifying specific microbial differences associated with each treatment modality.

Methods

A total of 42 individuals diagnosed with PD, along with 38 age‐matched household control participants, contributed stool samples for microbiota characterization. Differences in the gut microbiota across various groups of PD patients and their households were identified through comprehensive sequencing of the 16S rRNA gene amplicon sequencing. Key Results Differences in microbial communities were observed between PD patients and controls, as well as between PD patients receiving pharmacological treatment and those with STN‐DBS. Pharmacologically treated advanced PD patients have higher gastrointestinal dysfunctions. Gut microbiota profile linked to STN‐DBS and reduced levodopa consumption, characterized by its anti‐inflammatory properties, might play a role in diminishing gastrointestinal dysfunction relative to only pharmacological treatments. Conclusions & Inferences Advanced PD patients on medication exhibit more gastrointestinal issues, despite relatively stable microbial diversity, indicating a complex interaction between gut microbiota, PD progression, and treatment effects. An imbalanced gut–brain axis, particularly due to reduced butyrate production, may lead to constipation by affecting the enteric nervous system, which emphasizes the need to incorporate gut microbiome insights into treatment strategies.

Subjects

MeSH terms (MEDLINE)

Parkinson DiseaseGastrointestinal MicrobiomeDeep Brain StimulationHumansMaleFemaleMiddle AgedAgedAntiparkinson AgentsLevodopaGastrointestinal DiseasesSubthalamic Nucleus

Author keywords

Parkinson's diseasegut microbiotalevodopasurgical management

Substances

Antiparkinson AgentsLevodopa

Authors and institutions

  • Department of Pathophysiology, Jagiellonian University, Collegium Medicum, Kraków, Poland.
  • Department of Neurology, Medical College, Jagiellonian University, Kraków, Poland.
  • Department of Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Maurice Müller Laboratories, Department for Biomedical Research, University of Bern, Bern, Switzerland.
  • Department of Neurosurgery and Neurotraumatology, Medical College, Jagiellonian University, Kraków, Poland.

ORCID profiles: Agnieszka Gorecka-Mazur, Bahtiyar Yilmaz

Funding

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Narodowe Centrum Nauki

Cite

APA

Gorecka-Mazur, A., Krygowska-Wajs, A., Furgala, A., Li, J., Misselwitz, B., Pietraszko, W., Kwinta, B., & Yilmaz, B. (2024). Associations between gut microbiota characteristics and non‐motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients. Neurogastroenterology & Motility, 36(8). https://doi.org/10.1111/nmo.14846

Vancouver

Gorecka-Mazur A, Krygowska-Wajs A, Furgala A, Li J, Misselwitz B, Pietraszko W, et al. Associations between gut microbiota characteristics and non‐motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients. Neurogastroenterology & Motility. 2024;36(8). doi:10.1111/nmo.14846

BibTeX
@article{GoreckaMazur2024,
  author = {Gorecka-Mazur, Agnieszka and Krygowska-Wajs, Anna and Furgala, Agata and Li, Jiaqi and Misselwitz, Benjamin and Pietraszko, Wojciech and Kwinta, Borys and Yilmaz, Bahtiyar},
  title = {Associations between gut microbiota characteristics and non‐motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients},
  journal = {Neurogastroenterology & Motility},
  year = {2024},
  volume = {36},
  number = {8},
  doi = {10.1111/nmo.14846}
}
Start for free →